Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type | Tumor Size | isBackUp |
A1 | 1 | 72 | M | Bladder | Low-grade urothelial carcinoma (sparse) | * | T3N0M0 | IIIA | Malignant | 4*3*2 | N |
A2 | 2 | 51 | M | Bladder | Low-grade urothelial carcinoma | * | T1N0M0 | I | Malignant | 6*4*2 | N |
A3 | 3 | 59 | F | Bladder | Low-grade urothelial carcinoma | * | T1N0M0 | I | Malignant | 4*3.5*3.5 | N |
A4 | 4 | 79 | F | Bladder | Low-grade urothelial carcinoma | * | T2N0M0 | II | Malignant | 10*5*1.5 | N |
A5 | 5 | 45 | F | Bladder | Low-grade urothelial carcinoma | * | T1N0M0 | I | Malignant | 3*2*1.5 | N |
A6 | 6 | 72 | M | Bladder | Low-grade urothelial carcinoma | * | T1N0M0 | I | Malignant | 5*5*2.5 | N |
A7 | 7 | 42 | M | Bladder | Low-grade urothelial carcinoma | * | T1N0M0 | I | Malignant | 4*3*3 | N |
A8 | 8 | 71 | M | Bladder | Low-grade urothelial carcinoma | * | T2bN0M0 | II | Malignant | 4.5*3*2 | N |
A9 | 9 | 50 | M | Bladder | Low-grade urothelial carcinoma | * | T1N0M0 | I | Malignant | 5*3*2 | N |
A10 | 10 | 25 | F | Bladder | Low-grade urothelial carcinoma | * | T2N0M0 | II | Malignant | 13*10*8 | N |
A11 | 11 | 48 | M | Bladder | High grade urothelial carcinoma | * | T2N0M0 | II | Malignant | 3*2*2 | N |
A12 | 12 | 73 | F | Bladder | High grade urothelial carcinoma | * | T2N0M0 | II | Malignant | 3*2*2 | N |
A13 | 13 | 71 | M | Bladder | High grade urothelial carcinoma (interstitial) | * | T3bN0M0 | IIIA | Malignant | 8*7 | N |
A14 | 14 | 45 | F | Bladder | High grade urothelial carcinoma | * | T3N0M0 | IIIA | Malignant | 10*7*7 | N |
A15 | 15 | 52 | M | Bladder | High grade urothelial carcinoma | * | T2N0M0 | II | Malignant | 6*5*2 | N |
B1 | 16 | 72 | M | Bladder | Low-grade urothelial carcinoma | * | T3N0M0 | IIIA | Malignant | 4*3*2 | N |
B2 | 17 | 51 | M | Bladder | Low-grade urothelial carcinoma | * | T1N0M0 | I | Malignant | 6*4*2 | N |
B3 | 18 | 59 | F | Bladder | Low-grade urothelial carcinoma | * | T1N0M0 | I | Malignant | 4*3.5*3.5 | N |
B4 | 19 | 79 | F | Bladder | Low-grade urothelial carcinoma | * | T2N0M0 | II | Malignant | 10*5*1.5 | N |
B5 | 20 | 45 | F | Bladder | Low-grade urothelial carcinoma | * | T1N0M0 | I | Malignant | 3*2*1.5 | N |
B6 | 21 | 72 | M | Bladder | Low-grade urothelial carcinoma | * | T1N0M0 | I | Malignant | 5*5*2.5 | N |
B7 | 22 | 42 | M | Bladder | Low-grade urothelial carcinoma | * | T1N0M0 | I | Malignant | 4*3*3 | N |
B8 | 23 | 71 | M | Bladder | Low-grade urothelial carcinoma | * | T2bN0M0 | II | Malignant | 4.5*3*2 | N |
B9 | 24 | 50 | M | Bladder | Low-grade urothelial carcinoma | * | T1N0M0 | I | Malignant | 5*3*2 | N |
B10 | 25 | 25 | F | Bladder | Low-grade urothelial carcinoma | * | T2N0M0 | II | Malignant | 13*10*8 | N |
B11 | 26 | 48 | M | Bladder | High grade urothelial carcinoma | * | T2N0M0 | II | Malignant | 3*2*2 | N |
B12 | 27 | 73 | F | Bladder | High grade urothelial carcinoma | * | T2N0M0 | II | Malignant | 3*2*2 | N |
B13 | 28 | 71 | M | Bladder | High grade urothelial carcinoma | * | T3bN0M0 | IIIA | Malignant | 8*7 | N |
B14 | 29 | 45 | F | Bladder | High grade urothelial carcinoma | * | T3N0M0 | IIIA | Malignant | 10*7*7 | N |
B15 | 30 | 52 | M | Bladder | High grade urothelial carcinoma | * | T2N0M0 | II | Malignant | 6*5*2 | N |
C1 | 31 | 69 | M | Bladder | High grade urothelial carcinoma | * | T2aN0M0 | II | Malignant | 2.5*2.5*2.5 | N |
C2 | 32 | 35 | M | Bladder | High grade urothelial carcinoma | * | T2aN0M0 | II | Malignant | * | N |
C3 | 33 | 65 | M | Bladder | High grade urothelial carcinoma | * | T1N0M0 | I | Malignant | 3*3*1 | N |
C4 | 34 | 70 | M | Bladder | High grade urothelial carcinoma | * | T2aN0M0 | II | Malignant | 6*5*3 | N |
C5 | 35 | 44 | M | Bladder | High grade urothelial carcinoma (sparse) | * | T2N0M0 | II | Malignant | * | N |
C6 | 36 | 70 | M | Bladder | High grade urothelial carcinoma | * | T2bN0M0 | II | Malignant | 5*4*3 | N |
C7 | 37 | 42 | M | Bladder | High grade urothelial carcinoma | * | T2N0M0 | II | Malignant | 3*2*1 | N |
C8 | 38 | 67 | M | Bladder | High grade urothelial carcinoma | * | T2aN0M0 | II | Malignant | 4*3*3 | N |
C9 | 39 | 56 | M | Bladder | High grade urothelial carcinoma (sparse) | * | T3N0M0 | IIIA | Malignant | * | N |
C10 | 40 | 33 | M | Bladder | High grade urothelial carcinoma | * | T3N1M0 | IIIA | Malignant | * | N |
C11 | 41 | 65 | F | Bladder | High grade urothelial carcinoma (sparse) | * | T3aN0M0 | IIIA | Malignant | 4*3*2 | N |
C12 | 42 | 37 | F | Bladder | High grade urothelial carcinoma | * | T2bN0M0 | II | Malignant | * | N |
C13 | 43 | 45 | F | Bladder | High grade urothelial carcinoma | * | T1N0M0 | I | Malignant | * | N |
C14 | 44 | 55 | M | Bladder | High grade urothelial carcinoma | * | T2N0M0 | II | Malignant | 3*2*1.5 | N |
C15 | 45 | 70 | F | Bladder | High grade urothelial carcinoma | * | T2N0M0 | II | Malignant | 3*2*2 | N |
D1 | 46 | 69 | M | Bladder | High grade urothelial carcinoma | * | T2aN0M0 | II | Malignant | 2.5*2.5*2.5 | N |
D2 | 47 | 35 | M | Bladder | High grade urothelial carcinoma | * | T2aN0M0 | II | Malignant | * | N |
D3 | 48 | 65 | M | Bladder | High grade urothelial carcinoma | * | T1N0M0 | I | Malignant | 3*3*1 | N |
D4 | 49 | 70 | M | Bladder | High grade urothelial carcinoma | * | T2aN0M0 | II | Malignant | 6*5*3 | N |
D5 | 50 | 44 | M | Bladder | High grade urothelial carcinoma (sparse) | * | T2N0M0 | II | Malignant | * | N |
D6 | 51 | 70 | M | Bladder | High grade urothelial carcinoma | * | T2bN0M0 | II | Malignant | 5*4*3 | N |
D7 | 52 | 42 | M | Bladder | High grade urothelial carcinoma | * | T2N0M0 | II | Malignant | 3*2*1 | N |
D8 | 53 | 67 | M | Bladder | High grade urothelial carcinoma | * | T2aN0M0 | II | Malignant | 4*3*3 | N |
D9 | 54 | 56 | M | Bladder | High grade urothelial carcinoma | * | T3N0M0 | IIIA | Malignant | * | N |
D10 | 55 | 33 | M | Bladder | High grade urothelial carcinoma | * | T3N1M0 | IIIA | Malignant | * | N |
D11 | 56 | 65 | F | Bladder | High grade urothelial carcinoma | * | T3aN0M0 | IIIA | Malignant | 4*3*2 | N |
D12 | 57 | 37 | F | Bladder | High grade urothelial carcinoma | * | T2bN0M0 | II | Malignant | * | N |
D13 | 58 | 45 | F | Bladder | High grade urothelial carcinoma | * | T1N0M0 | I | Malignant | * | N |
D14 | 59 | 55 | M | Bladder | High grade urothelial carcinoma | * | T2N0M0 | II | Malignant | 3*2*1.5 | N |
D15 | 60 | 70 | F | Bladder | High grade urothelial carcinoma | * | T2N0M0 | II | Malignant | 3*2*2 | N |
E1 | 61 | 70 | F | Bladder | High grade urothelial carcinoma | * | T3aN0M0 | IIIA | Malignant | * | N |
E2 | 62 | 78 | F | Bladder | High grade urothelial carcinoma | * | T1N0M0 | I | Malignant | 7*5*2 | N |
E3 | 63 | 65 | M | Bladder | High grade urothelial carcinoma | * | T1N0M0 | I | Malignant | 3*2*1 | N |
E4 | 64 | 50 | F | Bladder | High grade urothelial carcinoma | * | T2N0M0 | II | Malignant | 3*2*2 | N |
E5 | 65 | 82 | M | Bladder | High grade urothelial carcinoma | * | T3N0M0 | IIIA | Malignant | * | N |
E6 | 66 | 61 | M | Bladder | High grade urothelial carcinoma | * | T2N0M0 | II | Malignant | * | N |
E7 | 67 | 60 | F | Bladder | High grade urothelial carcinoma | * | T3aN0M0 | IIIA | Malignant | * | N |
E8 | 68 | 58 | M | Bladder | High grade urothelial carcinoma | * | T2N0M0 | II | Malignant | * | N |
E9 | 69 | 77 | F | Bladder | High grade urothelial carcinoma | * | T1N0M0 | I | Malignant | 2*1.5*1 | N |
E10 | 70 | 74 | M | Bladder | High grade urothelial carcinoma | * | T3N0M0 | IIIA | Malignant | * | N |
E11 | 71 | 68 | M | Bladder | High grade urothelial carcinoma | * | T3bN0M0 | IIIA | Malignant | * | N |
E12 | 72 | 66 | M | Bladder | High grade urothelial carcinoma | * | T2N0M0 | II | Malignant | * | N |
E13 | 73 | 60 | F | Bladder | High grade urothelial carcinoma | * | T3bN0M0 | IIIA | Malignant | 3*2*2 | N |
E14 | 74 | 67 | M | Bladder | High grade urothelial carcinoma | * | T3N0M0 | IIIA | Malignant | 7*4*3 | N |
E15 | 75 | 56 | M | Bladder | High grade urothelial carcinoma | * | T2N0M0 | II | Malignant | 3*2*1 | N |
F1 | 76 | 70 | F | Bladder | High grade urothelial carcinoma | * | T3aN0M0 | IIIA | Malignant | * | N |
F2 | 77 | 78 | F | Bladder | High grade urothelial carcinoma | * | T1N0M0 | I | Malignant | 7*5*2 | N |
F3 | 78 | 65 | M | Bladder | High grade urothelial carcinoma | * | T1N0M0 | I | Malignant | 3*2*1 | N |
F4 | 79 | 50 | F | Bladder | High grade urothelial carcinoma | * | T2N0M0 | II | Malignant | 3*2*2 | N |
F5 | 80 | 82 | M | Bladder | High grade urothelial carcinoma | * | T3N0M0 | IIIA | Malignant | * | N |
F6 | 81 | 61 | M | Bladder | High grade urothelial carcinoma | * | T2N0M0 | II | Malignant | * | N |
F7 | 82 | 60 | F | Bladder | High grade urothelial carcinoma | * | T3aN0M0 | IIIA | Malignant | * | N |
F8 | 83 | 58 | M | Bladder | High grade urothelial carcinoma | * | T2N0M0 | II | Malignant | * | N |
F9 | 84 | 77 | F | Bladder | High grade urothelial carcinoma | * | T1N0M0 | I | Malignant | 2*1.5*1 | N |
F10 | 85 | 74 | M | Bladder | High grade urothelial carcinoma (sparse) | * | T3N0M0 | IIIA | Malignant | * | N |
F11 | 86 | 68 | M | Bladder | High grade urothelial carcinoma | * | T3bN0M0 | IIIA | Malignant | * | N |
F12 | 87 | 66 | M | Bladder | High grade urothelial carcinoma | * | T2N0M0 | II | Malignant | * | N |
F13 | 88 | 60 | F | Bladder | High grade urothelial carcinoma | * | T3bN0M0 | IIIA | Malignant | 3*2*2 | N |
F14 | 89 | 67 | M | Bladder | High grade urothelial carcinoma | * | T3N0M0 | IIIA | Malignant | 7*4*3 | N |
F15 | 90 | 56 | M | Bladder | High grade urothelial carcinoma | * | T2N0M0 | II | Malignant | 3*2*1 | N |
G1 | 91 | 57 | F | Bladder | High grade urothelial carcinoma | * | T3N0M0 | IIIA | Malignant | 6*4*4 | N |
G2 | 92 | 42 | M | Bladder | High grade urothelial carcinoma | * | T2N0M0 | II | Malignant | 5*5*4 | N |
G3 | 93 | 74 | F | Bladder | High grade urothelial carcinoma (interstitial) | * | T2bN0M0 | II | Malignant | * | N |
G4 | 94 | 45 | M | Bladder | High grade urothelial carcinoma | * | T3bN0M0 | IIIA | Malignant | * | N |
G5 | 95 | 46 | F | Bladder | Adenocarcinoma | 2 | T3bN2M0 | IIIB | Malignant | * | N |
G6 | 96 | 60 | M | Bladder | Adenocarcinoma | 2 | T2N1M0 | IIIA | Malignant | * | N |
G7 | 97 | 48 | F | Bladder | Adenocarcinoma with degeneration | 2 | T3N0M0 | IIIA | Malignant | 10*6*3 | N |
G8 | 98 | 74 | F | Bladder | Adenocarcinoma | 2 | T1N0M0 | I | Malignant | 3*2*2 | N |
G9 | 99 | 57 | M | Bladder | Adenocarcinoma | 2 | T1N0M0 | I | Malignant | * | N |
G10 | 100 | 76 | M | Bladder | Adenocarcinoma | 2--3 | T4N0M0 | IIIA | Malignant | * | N |
G11 | 101 | 58 | M | Bladder | Adenocarcinoma | 3 | T2N0M0 | II | Malignant | 4.5 | N |
G12 | 102 | 65 | M | Bladder | Adenocarcinoma | 3 | T4N0M0 | IIIA | Malignant | 2.5*1.5*1 | N |
G13 | 103 | 70 | M | Bladder | Adenocarcinoma | 3 | T2bN0M0 | II | Malignant | * | N |
G14 | 104 | 43 | M | Bladder | Adenocarcinoma (sparse) | 3 | T3aN0M0 | IIIA | Malignant | 10*7*6 | N |
G15 | 105 | 65 | M | Bladder | Adenocarcinoma (degeneration and necrosis) | 3 | T3bN0M0 | IIIA | Malignant | 3*1.5 | N |
H1 | 106 | 57 | F | Bladder | High grade urothelial carcinoma | * | T3N0M0 | IIIA | Malignant | 6*4*4 | N |
H2 | 107 | 42 | M | Bladder | High grade urothelial carcinoma | * | T2N0M0 | II | Malignant | 5*5*4 | N |
H3 | 108 | 74 | F | Bladder | High grade urothelial carcinoma | * | T2bN0M0 | II | Malignant | * | N |
H4 | 109 | 45 | M | Bladder | High grade urothelial carcinoma | * | T3bN0M0 | IIIA | Malignant | * | N |
H5 | 110 | 46 | F | Bladder | Adenocarcinoma | 2 | T3bN2M0 | IIIB | Malignant | * | N |
H6 | 111 | 60 | M | Bladder | Adenocarcinoma | 2 | T2N1M0 | IIIA | Malignant | * | N |
H7 | 112 | 48 | F | Bladder | Adenocarcinoma with degeneration | 2 | T3N0M0 | IIIA | Malignant | 10*6*3 | N |
H8 | 113 | 74 | F | Bladder | Adenocarcinoma | 2 | T1N0M0 | I | Malignant | 3*2*2 | N |
H9 | 114 | 57 | M | Bladder | Adenocarcinoma | 2 | T1N0M0 | I | Malignant | * | N |
H10 | 115 | 76 | M | Bladder | Adenocarcinoma (sparse) | 2--3 | T4N0M0 | IIIA | Malignant | * | N |
H11 | 116 | 58 | M | Bladder | Adenocarcinoma | 3 | T2N0M0 | II | Malignant | 4.5 | N |
H12 | 117 | 65 | M | Bladder | Adenocarcinoma | 3 | T4N0M0 | IIIA | Malignant | 2.5*1.5*1 | N |
H13 | 118 | 70 | M | Bladder | Adenocarcinoma | 3 | T2bN0M0 | II | Malignant | * | N |
H14 | 119 | 43 | M | Bladder | Adenocarcinoma | 3 | T3aN0M0 | IIIA | Malignant | 10*7*6 | N |
H15 | 120 | 65 | M | Bladder | Adenocarcinoma (interstitial) | 3 | T3bN0M0 | IIIA | Malignant | 3*1.5 | N |
I1 | 121 | 50 | M | Bladder | Adenocarcinoma | 3 | T3N0M0 | IIIA | Malignant | 6*5*2.5 | N |
I2 | 122 | 53 | M | Bladder | Squamous cell carcinoma | 1 | T2N0M0 | II | Malignant | 4.5*4.5*3 | N |
I3 | 123 | 46 | M | Bladder | Squamous cell carcinoma | 1 | T2aN0M0 | II | Malignant | * | N |
I4 | 124 | 51 | M | Bladder | Squamous cell carcinoma | 2 | T2bN2M0 | IIIB | Malignant | * | N |
I5 | 125 | 68 | M | Bladder | Squamous cell carcinoma (inflammation) | * | T3aN0M0 | IIIA | Malignant | 6*3.5*3 | N |
I6 | 126 | 67 | M | Bladder | Squamous cell carcinoma | 2 | T3aN0M0 | IIIA | Malignant | 4*4*3.5 | N |
I7 | 127 | 57 | M | Bladder | Squamous cell carcinoma | 3 | T3aN0M0 | IIIA | Malignant | * | N |
I8 | 128 | 52 | M | Bladder | Squamous cell carcinoma | 3 | T3N0M0 | IIIA | Malignant | * | N |
I9 | 129 | 76 | F | Bladder | Complicated carcinoma | * | T2N0M0 | II | Malignant | * | N |
I10 | 130 | 62 | M | Bladder | Leiomyosarcoma | * | T2bN0M0 | II | Malignant | 6*2 | N |
I11 | 131 | 78 | F | Bladder | Chronic cystitis | * | * | * | Inflammation | * | N |
I12 | 132 | 53 | M | Bladder | Chronic cystitis | * | * | * | Inflammation | * | N |
I13 | 133 | 73 | M | Bladder | Chronic cystitis | * | * | * | Inflammation | * | N |
I14 | 134 | 75 | M | Bladder | Chronic cystitis | * | * | * | Inflammation | * | N |
I15 | 135 | 46 | F | Bladder | Chronic cystitis | * | * | * | Inflammation | * | N |
J1 | 136 | 50 | M | Bladder | Adenocarcinoma | 3 | T3N0M0 | IIIA | Malignant | 6*5*2.5 | N |
J2 | 137 | 53 | M | Bladder | Squamous cell carcinoma | 1 | T2N0M0 | II | Malignant | 4.5*4.5*3 | N |
J3 | 138 | 46 | M | Bladder | Squamous cell carcinoma | 1 | T2aN0M0 | II | Malignant | * | N |
J4 | 139 | 51 | M | Bladder | Squamous cell carcinoma | 2 | T2bN2M0 | IIIB | Malignant | * | N |
J5 | 140 | 68 | M | Bladder | Squamous cell carcinoma | 2 | T3aN0M0 | IIIA | Malignant | 6*3.5*3 | N |
J6 | 141 | 67 | M | Bladder | Squamous cell carcinoma | 2 | T3aN0M0 | IIIA | Malignant | 4*4*3.5 | N |
J7 | 142 | 57 | M | Bladder | Squamous cell carcinoma | 3 | T3aN0M0 | IIIA | Malignant | * | N |
J8 | 143 | 52 | M | Bladder | Squamous cell carcinoma | 3 | T3N0M0 | IIIA | Malignant | * | N |
J9 | 144 | 76 | F | Bladder | Complicated carcinoma | * | T2N0M0 | II | Malignant | * | N |
J10 | 145 | 62 | M | Bladder | Leiomyosarcoma | * | T2bN0M0 | II | Malignant | 6*2 | N |
J11 | 146 | 78 | F | Bladder | Chronic cystitis | * | * | * | Inflammation | * | N |
J12 | 147 | 53 | M | Bladder | Chronic cystitis | * | * | * | Inflammation | * | N |
J13 | 148 | 73 | M | Bladder | Chronic cystitis | * | * | * | Inflammation | * | N |
J14 | 149 | 75 | M | Bladder | Chronic cystitis | * | * | * | Inflammation | * | N |
J15 | 150 | 46 | F | Bladder | Chronic cystitis | * | * | * | Inflammation | * | N |
Tissue Marker |